May 18, 2022 / 02:30PM GMT
Arnaud Delépine -
Good morning, good afternoon and good evening to everyone. I'm Arnaud from Sanofi IR team. It's a pleasure to welcome you to this call dedicated to accountings. I remind you that this call is to address specific accounting questions and not business-related questions. You can find a slide of this call on the Investor page of our website at sanofi.com. At the end of the slide deck in the appendix, you will find GenMed '21 quarterly sales by core and noncore assets as requested by many of you.
Let me start with a few logistical things. (Operator Instructions)
Moving to Slide 3. I would like to remind you that information presented in this call contain forward-looking statements that involve known and unknown risks, uncertainties and other factors that may cause actual results to differ materially. I refer you to our Form 20-F document on file with SEC and also our Document d'Enregistrement Universel for a description of those risk factors.
Slide 4. Our speaker on the call today is Laurent Gilhodes, Head of Group Controlling and Alliances. I'm also
Sanofi SA Accounting Call Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers